| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $904K | -82.0% |
| SG&A Expense | $14.7M | +37.1% |
| Operating Income | -$15.6M | +0.9% |
| Net Income | -$18.1M | -14.3% |
| EPS (Basic) | -$5.33 | +88.9% |
| EPS (Diluted) | -$5.33 | +88.9% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $163K | -95.6% |
| Current Assets | $83.5M | +1584.3% |
| Total Assets | $85.4M | +1140.8% |
| Current Liabilities | $27.5M | +779.1% |
| Total Liabilities | $27.6M | +741.6% |
| Stockholders' Equity | -$3.9M | -207.6% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$9.2M | +25.5% |
| Investing Cash Flow | $88K | +117.6% |
| Financing Cash Flow | $5.6M | -63.3% |